Elderly couple dies by suicide in Bengaluru old age home month after moving in
An elderly couple died by suicide at an old-age home in Bengaluru's JP Nagar a month after their son moved them to the facility.The couple's son, Vijay, admitted his parents, Krishnamurthy, aged 81, and Radha, aged 74, to the old age home on May 15, reportedly after repeated domestic arguments. The disputes stemmed from disagreements over the daughter-in-law's cooking, which the elderly parents were unhappy with.advertisementThis was not the first time Vijay had sent his parents to an old age home. In 2021, he had admitted them to another home in Byatarayanapura following similar issues, only to bring them back in 2023. However, tensions at home continued, leading to their recent admission to the JP Nagar facility with a monthly fee of Rs 7,500.
Shobha, the supervisor of the old age home, recounted that the couple had seemed fine when they were admitted. 'On Monday evening, they were watching TV together. Radha wanted to watch her favourite serial, while Krishnamurthy preferred devotional songs. They argued over this and then went into their room,' she said.According to the staff, the incident came to light when the couple failed to open their door on Tuesday morning. When the staff broke in, both were found hanging inside their room. The incident has been recorded as an Unnatural Death Report (UDR) at the Talaghattapura Police Station.advertisementWhile the staff suspect that the disagreement over TV might have been the immediate trigger, they believe prolonged emotional distress and feelings of abandonment may have driven the couple to take this extreme step.- Ends
IN THIS STORY#Bengaluru#Karnataka
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
33 minutes ago
- Business Standard
Consumer body backs medical negligence claim, awards ₹10 lakh compensation
The National Consumer Disputes Redressal Commission upheld a state consumer commission order holding a doctor responsible for medical negligence while reducing the compensation for mental agony to Rs 10 lakh, according to an official order. The commission comprising presiding member Bijoy Kumar and member Justice Saroj Yadav, was hearing the appeal filed by Dr P Yashodhara challenging the March 2019 order of the Andhra Pradesh State Consumer Disputes Redressal Commission awarding Rs 30 lakh as compensation to the complainant for mental agony, along with other costs, after holding the doctor guilty of medical negligence. The complainant, K Sreelatha, alleged that because of the doctor's negligence during a forceps delivery performed on April 17, 2011, the baby suffered serious crush injuries to the scalp and his right ear pinna was also crushed and detached. Sreelatha further alleged that due to these injuries, the baby sustained brain damage and had become mentally disabled. In an order dated June 6, the national commission said that the doctor's hospital did not obtain "informed consent" for surgery, and the baby suffered injuries on his scalp and perichondritis of the ears, evidenced by the discharge summary of the second hospital wherein the baby boy was admitted for further treatment. The commission, however, said that it was difficult to correlate the injuries suffered on the scalp with the subsequent "mental retardation" suffered by the boy as no evidence for it was submitted. "The state commission has gone into detail and given a well-reasoned order, and we find no illegality in holding the appellant doctor responsible for the injury caused to the scalp of the baby, which had necessitated further treatment in another hospital. Thus, medical negligence is established," it added. The commission also said that the compensation of Rs 30 lakh awarded for suffering mental agony appeared to be on the higher side, and the state commission did not provide any finding on how the amount was arrived at. It said, "There is a stay of around one and a half months in Chennai for the treatment in the second hospital. For this period, the amount of Rs 10 lakh as compensation would be in order considering the quantum of injury and the gravity of negligence in using forceps." The commission also directed payment of Rs 72,530 for the treatment expenses and Rs 50,000 for litigation costs.
Indian Express
4 hours ago
- Indian Express
Whoop, Garmin, Fitbit: Best premium fitness trackers in 2025
Fitness trackers are getting smarter, sleeker and more feature-packed than ever. From real-time heart rate and SpO2 tracking to advanced sleep analysis, today's wearables are built for much more than counting steps. Whether you're a gym regular or just trying to build better habits, here's a look at some of the best premium fitness trackers available in India right now. Fitbit's Charge 6 blends smart features with serious fitness tracking. It offers ECG, a form of advanced heart tracking, built-in GPS, blood oxygen saturation (SpO2) tracking, and workout detection across more than 40 exercise types. The bright AMOLED screen displays Google Maps, Wallet, and even YouTube Music controls. Fitbit's Active Zone Minutes help optimise workout intensity, while the 7-day battery life ensures minimal downtime. The Charge 6 also syncs with gym equipment (if able to) and includes six months of Fitbit Premium, giving access to deeper insights and personalised recommendations. You can buy it for as low as Rs 14,799. For data-focused users, the Garmin Vivosmart 5 offers a reliable and no-fuss fitness companion. It features a monochrome OLED touchscreen and tracks heart rate, SpO2, stress levels, sleep stages, and even energy levels through Garmin's 'Body Battery' metric. While there is no built-in GPS, it lets you track your location when using the phone GPS. Safety features include emergency alerts and LiveTrack. With up to 7 days of battery life, this slim and lightweight tracker has a water resistance level of up to 50 m deep, making it ideal for both workouts and showers. It is currently selling for Rs 12,990. The FitVII Ole is a feature-rich tracker equipped with a 1.78-inch AMOLED display, 24/7 heart rate, SpO2, blood pressure tracking, and sleep analysis. It supports over 100 sport modes and comes with IP68 water and dust resistance. You also get smart notifications, weather updates, and breathing training. The Ole stands out with its Apple Watch-inspired design and customisable watch faces. The device claims up to 7 days of battery life with regular use, making it one of the best-looking smart trackers under Rs 11,000. It is available on Amazon for Rs 10,878. Favoured by elite athletes like Virat Kohli and LeBron James, the Whoop 4.0 doesn't have a display and focuses entirely on performance recovery, strain, and sleep metrics. The tracker pairs with a powerful app that offers detailed health analytics, daily recovery stores, and coaching insights. It features 24/7 monitoring of heart rate variability (HRV), skin temperature, and blood oxygen, and is waterproof up to 10 metres. The sensor fits into various accessories like arm sleeves or compression wear, and the minimalist design sets it apart from traditional wearables. However, a subscription is required to use the device. You can buy it for Rs 30,000 with a complimentary 12-month membership. For users who want a slim and simple fitness band, the Fitbit Inspire 3 offers great value. It includes heart rate tracking, SpO2, skin temperature variation, stress management, and sleep stage analysis. The bright AMOLED screen displays call, text, and app notifications. While it lacks built-in GPS, it supports connected GPS and offers up to 10 days of battery life. Lightweight and swimproof, the Inspire 3 also supports mindfulness sessions and guided breathing, making it a great entry-level premium tracker for everyday wellness. It is currently available for Rs 8,899. (This article has been curated by Arfan Jeelany, who is an intern with The Indian Express)
Indian Express
7 hours ago
- Indian Express
Delhi drugs control department cracks down on sale of fake cholesterol medicines
The Delhi drugs control department recently uncovered a multi-level distribution network involved in the sale and circulation of spurious Rosuvas F 20 tablets, a prescription drug used to manage cholesterol and triglyceride levels, officials said on Friday. The action followed a complaint from Sun Pharmaceutical Industries Ltd, which reported that fake versions of its Rosuvas F 20 tablets were being sold by a retail outlet in central Delhi. The complaint mentioned a multi-level supply chain involving multiple wholesalers and distributors across the city. Rosuvas F 20 is a fixed-dose combination drug containing Rosuvastatin (20 mg) and Fenofibrate (160 mg). It is commonly prescribed to patients who require medication to manage high cholesterol and triglyceride levels, especially when lifestyle changes alone are not sufficient. The drug plays a vital role in preventing serious cardiovascular conditions such as heart attacks and strokes. Drugs control department officials said Rosuvas F 20 tablets were a fast-moving drug, and on June 14 and 15, 1,800 spurious tablets worth Rs 88,000 were seized from two locations in Okhla and Bhagirath Palace. 'On June 14, we first received a complaint from Rajinder Nagar, but no stock was found. A link was established in Okhla and Bhagirath Palace, where raids were conducted,' an official said. Officials noted irregularities and a suspicious absence of genuine stock at several distribution points, which ultimately led them to a firm located in the Okhla Industrial Area. 'Visual inspection and comparison with authentic samples suggested that the seized products were spurious — their appearance and packaging did not match those of the legitimate manufacturer,' said an official. Here, additional suspect stock of Rosuvas F 20 was found. Legal samples were collected from Bhagirath Palace, Chandni Chowk—one of Delhi's busiest medicine markets—and sent to a government laboratory for quality testing, while manufacturer verification is also underway, officials revealed. The department has secured custody permission for the seized drugs through the Delhi High Court. 'We are now coordinating with authorities in other states to trace the full supply chain behind the fake medication,' the official said.
